Acute versus chronic leukemia
Acute leukemias — AML and ALL — require prompt treatment because immature cells crowd the marrow and normal blood production fails. Chronic leukemias — CML and CLL — often progress more slowly and may be monitored for a period. The distinction is made by morphology, flow cytometry and genetics, not by the blood count alone.
Related: Haematology → · Dr. Sachita Baniya profile → · All conditions →
Risk-adapted treatment
Treatment is selected according to subtype, genetic risk, measurable residual disease, age and fitness. Options include intensive chemotherapy, lower-intensity regimens, tyrosine kinase inhibitors, targeted agents, and allogeneic transplant for selected high-risk patients. Supportive care is planned from the first cycle.
- Induction and consolidation planning
- Targeted therapy by mutation or fusion
- MRD monitoring where validated
- Allogeneic transplant referral for high-risk disease
- Infection prevention and transfusion support
When to seek care urgently
Fever during low blood counts, severe bleeding, breathlessness at rest or new confusion requires emergency assessment. Do not wait for a routine appointment. Dr. Baniya consults at Kathmandu Neurology Clinic & Cognitive Center, Durbar Marg, and also practises at Kathmandu Cancer Center (KCC) Nepal, Civil Service Hospital, Kathmandu, and Advanced Care Hospital.